Biodesix announces expanded partnership to develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing
The EFOX system delivers highly sensitive, full-scan data that helps labs detect persistent compounds faster, with more confidence, and in compliance with tightening regulations
High-performance liquid chromatography (HPLC) stands as one of the foremost analytical techniques in use today. Its operational principle involves the separation of compounds according to their polarity. Unlike traditional liquid chromatography (LC), HPLC uses elevated pressure to propel the solvent through the column, significantly expediting separations while minimizing solvent usage.
Guest editorial features key takeaways from Balancing the Future Podcast, Season 1, Episode 3, by METTLER TOLEDO
Collaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting
Discover how advanced imaging technology is enabling continuous drug safety monitoring in liver organoids
Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts
Agreement will expand the availability of Gencurix’s in vitro diagnostic (IVD) assays using Droplet Digital™ PCR (ddPCR™) for clinical testing of critical oncology biomarkers across Europe